Overview

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose bioavailability of Torsemide tablets with Demadex
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
Anapharm
Treatments:
Torsemide